Approximately 50 thousand Pfizer-BioNTech COVID-19 jabs for children aged 5-12 will arrive in Georgia in the second quarter of the year, said Amiran Gamkrelidze, Head of the National Center for Diseases Control and Public Health (NCDC).
Risk-group kids will receive the shots first.
“Vaccination will then continue if desired,” Gamkrelidze said.
The World Health Organization on January 21 recommended extending the use of a fewer dosage of Pfizer’s COVID-19 vaccine to children aged 5 to 11 years old. The Pfizer COVID-19 vaccine for children is over 90% effective at preventing COVID-19 in children aged 5 through 11 years.